Many Americans would resist using tax dollars to pay people to stay sober. But that's the approach the data suggest.
The Daily Yonder on MSN
The 'hub-and-spoke' model for addiction treatment in North Carolina
Holly Warren was recently leafing through one of her old medical school textbooks, trying to recall how much instruction ...
Los Angeles County Public Health Department officials say accidental drug overdose deaths are down for the third year in a ...
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself.
A new review explores how GLP-1 receptor agonists may blunt alcohol and drug reward signals, opening a promising but still unproven path toward repurposed treatments for addiction. Review: The role of ...
The Trump administration is proposing wastewater testing on a national level to try to ferret out data on illegal drug use in real time, according to a draft of a new drug control strategy obtained by ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. New data shows major differences across the United States in drug use, ...
ONDCP, SAMHSA and HUD Convene National Experts to Establish a Toolkit to Treat Addiction among Homeless Individuals. In support of President Trump’s Executive Order on Ending Crime and Disorder on ...
An experimental medication was shown to achieve strong pain relief in early studies without the risks associated with typical opioids. The finding comes from the National Institute on Drug Abuse (NIDA ...
For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 drugs are not yet an approved addiction treatment. But the evidence base is ...
Weight-loss drugs such as Wegovy and Ozempic may become the new frontline warriors in treating and preventing drug and alcohol addiction, a large new study shows. The research, published Wednesday in ...
Researchers believe that GLP-1 drugs act on reward areas of the brain that are responsible for food cravings, making it possible that they silence cravings for addictive substances. The Conversation — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results